Finally, with regards to vascular alteration, the authors observed in another in vitro study that PTX3 circulating levels were significantly higher in sera from newly diagnosed SSc patients than in those from healthy donors and cyclophosphamide-treated SSc patients [91]. The gene discussed is PTX3; the disease is systemic sclerosis.